Clinical Trial Update: Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Gastrografin for the management of fecal impaction in patients with severe chronic constipation. The sponsor is Jinling Hospit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Fecal Impaction

Drugs mentioned

• Gastrografin (diatrizoate meglumine and diatrizoate sodium)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Fecal Impaction | Phase 2 | Status: UNKNOWN